UAB Digital Repository of Documents 91 records found  1 - 10nextend  jump to record: Search took 0.01 seconds. 
1.
12 p, 801.4 KB The Secondary Myelodysplastic Neoplasms (MDS) Jigsaw / Calvete, Oriol (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Mestre, Julia (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Jerez, Andrés (Vall d'Hebron Institut d'Oncologia) ; Sole, F (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
There is a great deal of controversy in the hematologic community regarding the classification of secondary myelodysplastic neoplasms (MDSs). Current classifications are based on the presence of genetic predisposition and MDS post-cytotoxic therapy (MDS-pCT) etiologies. [...]
2023 - 10.3390/cancers15051483
Cancers, Vol. 15 Núm. 5 (march 2023) , p. 1483  
2.
10 p, 1.3 MB Two-Time Multiplexed Targeted Next-Generation Sequencing Might Help the Implementation of Germline Screening Tools for Myelodysplastic Syndromes/Hematologic Neoplasms / Calvete, Oriol (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Mestre, Julia (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Risueño, Ruth M. (University of Atlántico Medio, Las Palmas) ; Manzanares Mileo, Ana (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Acha, Pamela (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Xicoy, Blanca (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Sole, F (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
Next-generation sequencing (NGS) tools have importantly helped the classification of myelodysplastic syndromes (MDS), guiding the management of patients. However, new concerns are under debate regarding their implementation in routine clinical practice for the identification of germline predisposition. [...]
2023 - 10.3390/biomedicines11123222
Biomedicines, Vol. 11 Núm. 12 (december 2023)  
3.
4.8 MB Implementación informática y validación de la prism 5 (psychiatric research interview for substance and mental disorders for DSM 5) / Tamarit Francés, Claudio ; Torrens, Marta, dir. ; Mestre Pinto, Juan Ignacio, dir.
Davant la necessitat de facilitar la detecció i el diagnòstic en mitjans assistencials i de recerca de la patologia psiquiàtrica en consumidors de substàncies, s'ha dut a terme la implementació informàtica i validació de l'instrument de diagnòstic de patologia dual "*Psychiatric *Research *Interview *for *Substance *and Mental *Disorders" segons criteris del *DSM 5 (*PRISM 5). [...]
Ante la necesidad de facilitar la detección y el diagnóstico en medios asistenciales y de investigación de la patología psiquiátrica en consumidores de sustancias, se ha llevado a cabo la implementación informática y validación del instrumento de diagnóstico de patología dual "Psychiatric Research Interview for Substance and Mental Disorders" según criterios del DSM 5 (PRISM 5). [...]
Given the need to facilitate the detection and diagnosis of psychiatric pathology in substance users in healthcare and research settings, we have carried out the computer implementation and validation of the diagnostic instrument for dual pathology "Psychiatric Research Interview for Substance and Mental Disorders" according to DSM 5 criteria (PRISM 5). [...]

2022  
4.
13 p, 3.8 MB Immunogenicity of Mycobacterial Extracellular Vesicles Isolated From Host-Related Conditions Informs About Tuberculosis Disease Status / Schirmer, Sebastian (University of Applied Sciences. Department of Medical Engineering and Biotechnology) ; Rauh, Lucas (University of Applied Sciences. Department of Medical Engineering and Biotechnology) ; Alebouyeh, Sogol (Universidad Autónoma de Madrid. Departamento de Medicina Preventiva y Salud Pública) ; Delgado-Velandia, Mario (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ; Salgueiro, Vivian C. (Universidad Autónoma de Madrid. Departamento de Medicina Preventiva y Salud Pública) ; Lerma, Laura (Universidad Autónoma de Madrid. Departamento de Medicina Preventiva y Salud Pública) ; Serrano-Mestre, José L. (Universidad Autónoma de Madrid. Departamento de Medicina Preventiva y Salud Pública) ; Azkargorta, Mikel (Basque Research and Technology Alliance) ; Elortza, Félix (Basque Research and Technology Alliance) ; Lavín, José L. (Basque Research and Technology Alliance) ; García, Maria Jesus (Universidad Autónoma de Madrid. Departamento de Medicina Preventiva y Salud Pública) ; Tórtola Fernández, María Teresa (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Gola, Susanne (University of Applied Sciences. Department of Medical Engineering and Biotechnology) ; Prados-Rosales, Rafael (Universidad Autónoma de Madrid. Departamento de Medicina Preventiva y Salud Pública)
Tuberculosis (TB) still represents a major global health problem affecting over 10 million people worldwide. The gold-standard procedures for TB diagnosis are culture and nucleic acid amplification techniques. [...]
2022 - 10.3389/fmicb.2022.907296
Frontiers in microbiology, Vol. 13 (June 2022) , art. 907296  
5.
11 p, 274.2 KB Safety of Drugs Used during the First Wave of COVID-19 : A Hospital-Registry-Based Study / Aguilera, Cristina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Danés Carreras, Immaculada (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Guillén, Elena (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Vimes, Alba (Hospital Universitari Vall d'Hebron) ; Bosch Ferrer, Montserrat (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Cereza García, Gloria (Hospital Universitari Vall d'Hebron) ; Sánchez-Montalvá, Adrián (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Campos Varela, Isabel (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ; Miarons, Marta (Hospital Universitari Vall d'Hebron) ; Mestre Torres, Jaume (Hospital Universitari Vall d'Hebron) ; Agustí Escasany, M. Antònia (Hospital Universitari Vall d'Hebron. Institut de Recerca)
The emergency of the coronavirus disease 2019 (COVID-19) pandemic led to the off-label use of drugs without data on their toxicity profiles in patients with COVID-19, or on their concomitant use. Patients included in the COVID-19 Patient Registry of a tertiary hospital during the first wave were analyzed to evaluate the adverse drug reactions (ADRs) with the selected treatments. [...]
2022 - 10.3390/diagnostics12071612
Diagnostics, Vol. 12 Núm. 7 (july 2022) , p. 1612  
6.
10 p, 635.2 KB BDNF and Cortisol in the Diagnosis of Cocaine-Induced Depression / Fonseca, Francina 1972- (Institut Hospital del Mar d'Investigacions Mèdiques) ; Mestre-Pinto, Joan Ignasi (Universitat Pompeu Fabra. Departament de Medicina i Ciències de la Vida) ; Rodríguez-Minguela, Rocío (Institut Hospital del Mar d'Investigacions Mèdiques) ; Papaseit, Esther (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Pérez-Mañá, Clara (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Langohr, Klaus (Institut Hospital del Mar d'Investigacions Mèdiques) ; Barbuti, Margherita (University Hospital of Pisa (Pisa, Itàlia)) ; Farre, Magi (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Torrens, Marta (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal)
Major depressive disorder (MDD) and cocaine use disorder (CUD) are related with disability and high mortality rates. The assessment and treatment of psychiatric comorbidity is challenging due to its high prevalence and its clinical severity, mostly due to suicide rates and the presence of medical comorbidities. [...]
2022 - 10.3389/fpsyt.2022.836771
Frontiers in psychiatry, Vol. 13 (march 2022)  
7.
19 p, 1.6 MB Update on Management Recommendations for Advanced Cutaneous Squamous Cell Carcinoma / García-Foncillas, Jesús (Universidad Autónoma de Madrid. Departamento de Medicina) ; Tejera-Vaquerizo, Antonio (Hospital San Juan de Dios (Còrdova, Espanya)) ; Sanmartín, Onofre (Fundació Institut Valencià d'Oncologia) ; Rojo, Federico (Hospital Universitario Fundación Jiménez Díaz) ; Mestre, Javier (Hospital Universitario Miguel Servet (Saragossa)) ; Martín, Salvador (Clínica Universidad de Navarra) ; Azinovic, Ignacio (Hospital Universitario Fundación Jiménez Díaz) ; Mesía, Ricard (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Cutaneous squamous cell carcinoma (cSCC) is the second most common form of skin cancer, which predominantly occurs on the head and neck. Early detection and treatment of primary tumours is crucial to limit progression and local invasion of deep tissues. [...]
2022 - 10.3390/cancers14030629
Cancers, Vol. 14 Núm. 3 (january 2022)  
8.
9 p, 833.3 KB A Biomarker to differentiate between primary and cocaine-induced major depression in cocaine use disorder : the role of platelet IRAS/Nischarin (I-Imidazoline receptor) / Keller, Benjamin (Universitat de les Illes Balears) ; Mestre-Pinto, Joan-Ignasi (Institut Hospital del Mar d'Investigacions Mèdiques) ; Álvaro-Bartolomé, María (Universitat de les Illes Balears) ; Martinez-Sanvisens, Diana (Institut Hospital del Mar d'Investigacions Mèdiques) ; Farre, Magi (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; García-Fuster, M. Julia (Universitat de les Illes Balears) ; García-Sevilla, Jesús A. (Universitat de les Illes Balears) ; Torrens, Marta (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal)
The association of cocaine use disorder (CUD) and comorbid major depressive disorder (MDD; CUD/MDD) is characterized by high prevalence and poor treatment outcomes. CUD/MDD may be primary (primary MDD) or cocaine-induced (CUD-induced MDD). [...]
2017 - 10.3389/fpsyt.2017.00258
Frontiers in psychiatry, Vol. 8 (december 2017) , art. 258  
9.
14 p, 1.4 MB The Tryptophan System in Cocaine-Induced Depression / Fonseca, Francina 1972- (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ; Mestre-Pintó, Joan-Ignasi (Institut Hospital del Mar d'Investigacions Mèdiques) ; Gomez-Gomez, A (Institut Hospital del Mar d'Investigacions Mèdiques) ; Martinez-Sanvisens, Diana (Hospital del Mar (Barcelona, Catalunya)) ; Rodríguez-Minguela, Rocío (Institut Hospital del Mar d'Investigacions Mèdiques) ; Papaseit, Esther (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Pérez-Mañá, Clara (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Langohr, Klaus (Institut Hospital del Mar d'Investigacions Mèdiques) ; Valverde, Olga (Institut Hospital del Mar d'Investigacions Mèdiques) ; Pozo, Óscar J. (Institut Hospital del Mar d'Investigacions Mèdiques) ; Farre, Magi (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Torrens, Marta (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal)
Major depression disorder (MDD) is the most prevalent psychiatric comorbid condition in cocaine use disorder (CUD). The comorbid MDD might be primary-MDD (CUD-primary-MDD) or cocaine-induced MDD (CUD-induced-MDD), and their accurate diagnoses and treatment is a challenge for improving prognoses. [...]
2020 - 10.3390/jcm9124103
Journal of clinical medicine, Vol. 9 (december 2020)  
10.
2 p, 529.3 KB XXXVI Asemblea Intercomarcal d'Estudiosos de Catalunya / Cortadella, Jordi 1960- ; Mestre i Campi, Jesús
1990
Plecs d'història local, Núm. 28 (1990) , p. 429-430  

UAB Digital Repository of Documents : 91 records found   1 - 10nextend  jump to record:
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.